CTMX
CytomX TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CTMX Profile
Cytomx Therapeutics, Inc.
A leader in the field of conditionally activated oncology therapeutics
151 Oyster Point Boulevard, Suite 400, South San Francisco, California 94080
--
CytomX Therapeutics, Inc., was incorporated in Delaware in September 2010. The Company is a clinical-stage, oncology-focused biopharmaceutical company focused on the development of novel conditionally activated biologics designed to target the tumor microenvironment. The Company's proprietary, multifunctional, multimodal PROBODY technology platform is designed to enable the conditional activation of biotherapeutic drug candidates within tumor microcycles while minimizing drug activity in healthy tissues and circulation.
